Page 33 - Read Online

Page 16 of 19 Ji et al. Rare Dis Orphan Drugs J 2023;2:26 https://dx.doi.org/10.20517/rdodj.2023.30

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Human Genetics Society of Australasia. Counting conditions and summary of conditions screened by programme. Available from:
https://hgsa.org.au/common/Uploaded%20files/pdfs/policies,%20position%20statements%20and%20guidelines/newborn%
20screening/2023%20PL01%20Counting%20Conditions%20and%20Summary%20of%20Conditions%20Screened%20by%
20Programme..pdf [Last accessed on 21 Nov 2023].
2. Wilcken B, Wiley V. Newborn screening. Pathology 2008;40:104-15. DOI PubMed
3. The Department of Health and Aged Care. Population-based screening framework. Available from: https://www.health.gov.au/
resources/publications/population-based-screening-framework?language=en [Last accessed on 21 Nov 2023].
4. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation;1968. Available from:
https://niercheck.nl/wp-content/uploads/2019/06/Wilson-Jungner-1968.pdf [Last accessed on 21 Nov 2023].
5. Coman D, Bhattacharya K. Extended newborn screening: an update for the general paediatrician. J Paediatr Child Health
2012;48:E68-72. DOI PubMed
6. Franková V, Driscoll RO, Jansen ME, et al; Members of the European Society of Human Genetics (ESHG)-EuroGentest Quality Sub-
Committee. Regulatory landscape of providing information on newborn screening to parents across Europe. Eur J Hum Genet
2021;29:67-78. DOI PubMed PMC
7. Australian Health Ministers’ Advisory Council. Newborn bloodspot screening national policy framework. Available from: https://
www.health.gov.au/sites/default/files/documents/2020/10/newborn-bloodspot-screening-national-policy-framework.pdf [Last
accessed on 21 Nov 2023].
8. Kariyawasam D, Russell JS, Wiley V, Alexander IE, Farrar MA. The implementation of newborn screening for spinal muscular
atrophy: the Australian experience. Genet Med 2020;22:557-65. DOI PubMed
9. Kariyawasam DS, D'Silva AM, Sampaio H, et al. Newborn screening for spinal muscular atrophy in Australia: a non-randomised
cohort study. Lancet Child Adolesc Health 2023;7:159-70. DOI PubMed
10. Dangouloff T, Boemer F, Servais L. Newborn screening of neuromuscular diseases. Neuromuscul Disord 2021;31:1070-80. DOI
PubMed
11. Shih STF, Keller E, Wiley V, Wong M, Farrar MA, Chambers GM. Economic evaluation of newborn screening for severe combined
immunodeficiency. Int J Neonatal Screen 2022;8:44. DOI PubMed
12. Shih STF, Keller E, Wiley V, Farrar MA, Wong M, Chambers GM. Modelling the cost-effectiveness and budget impact of a newborn
screening program for spinal muscular atrophy and severe combined immunodeficiency. Int J Neonatal Screen 2022;8:45. DOI
PubMed PMC
13. Huang X, Wu D, Zhu L, et al. Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies
inborn disorders of neonates. Orphanet J Rare Dis 2022;17:66. DOI PubMed PMC
14. Godler DE, Ling L, Gamage D, et al. Feasibility of screening for chromosome 15 imprinting disorders in 16 579 newborns by using a
novel genomic workflow. JAMA Netw Open 2022;5:e2141911. DOI PubMed PMC
15. Bourmaud A, Gallien S, Domon B. Parallel reaction monitoring using quadrupole-Orbitrap mass spectrometer: principle and
applications. Proteomics 2016;16:2146-59. DOI PubMed
16. Holm IA, Agrawal PB, Ceyhan-Birsoy O, et al; BabySeq Project Team. The babySeq project: implementing genomic sequencing in
newborns. BMC Pediatr 2018;18:225. DOI PubMed PMC
17. Roman TS, Crowley SB, Roche MI, et al. Genomic sequencing for newborn screening: results of the NC NEXUS project. Am J Hum
Genet 2020;107:596-611. DOI PubMed
18. Ceyhan-Birsoy O, Murry JB, Machini K, et al; BabySeq Project Team. Interpretation of genomic sequencing results in healthy and ill
newborns: results from the babyseq project. Am J Hum Genet 2019;104:76-93. DOI PubMed PMC
19. Sagan A, McDaid D, Rajan S, Farrington J, McKee M. Screening: when is it appropriate and how can we get it right? Copenhagen
(Denmark): European Observatory on Health Systems and Policies; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/
NBK559794/ [Last accessed on 21 Nov 2023].
20. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening
criteria over the past 40 years. Bull World Health Organ 2008;86:317-9. DOI PubMed
21. Andermann A, Blancquaert I, Beauchamp S, Costea I. Guiding policy decisions for genetic screening: developing a systematic and
transparent approach. Public Health Genomics 2010;14:9-16. DOI PubMed